The Peruvian market is dominated by a few major players, but SMEs like D & M Pharma Peru SAC serve niche markets. The 2024-2025 market is characterized by:
The primary revenue stream for D & M Pharma Peru SAC is likely B2B wholesale. They buy in bulk and sell to:
D & M Pharma Peru SAC likely competes with:
To survive, D & M Pharma must offer either lower prices, faster delivery to remote zones, or access to hard-to-find orphan drugs.
If you want, I can:
D & M Pharma Peru S.A.C.: A Key Player in Peru's Pharmaceutical Sector
D & M Pharma Peru S.A.C. is a prominent pharmaceutical enterprise based in Lima, Peru, specializing in the distribution and marketing of high-quality medicinal products. Incorporated on August 01, 2007, the company has established itself as a reliable partner in the Peruvian healthcare system, particularly through its strategic alliance with the Argentine Laboratorio Cassará. Company Overview and Origins
D & M Pharma began its journey in Peru in 2006, following its initial founding in Chile in 2003 by executives with extensive experience in the pharmaceutical industry. The company operates primarily as a wholesaler of miscellaneous nondurable goods, focusing on the pharmaceutical sector.
Strategic Alliance: In 2005, the company partnered with Laboratorio Cassará, an Argentine laboratory with over 65 years of experience.
Mission: Their core objective is to provide safe, effective, and accessible medications that improve patient quality of life while supporting medical professionals. d amp m pharma peru sac
Workforce: As of 2024, the company employs approximately 32 professionals dedicated to quality assurance and pharmaceutical marketing. Specialized Therapeutic Areas
D & M Pharma Peru S.A.C. focuses on specific medical niches, ensuring specialized care and high-standard products in the following areas:
Respiratory: Providing advanced solutions for pulmonary and airway conditions.
Dermatology: Offering a wide range of topical treatments and dermocosmetic products.
Ophthalmology: Managed through their specialized division, Novoplos.
Biotechnology: Leveraging modern science to provide innovative treatments. Key Products and Divisions
The company organizes its portfolio through five primary divisions, each dedicated to specific health needs:
Cassará: Covers dermatology, respiratory, and biotechnology lines.
Fouchard, Bailleul, and Feelderm: Specialized divisions for advanced dermatological care. Novoplos: Focused on ophthalmological solutions. The Peruvian market is dominated by a few
Specific products distributed by the group include Adapac (gel), Aerotrop (nebulization solutions), Anagen (capillary lotion), and Atopix (creams and emulsions). Quality Assurance and Pharmacovigilance
Patient safety is a cornerstone of operations at D & M Pharma Peru S.A.C.. The company maintains a robust Pharmacovigilance system to monitor and report adverse events, ensuring all distributed medications meet international safety standards. Recently, their Technical Director, Dr. Mery Luz Peña García, was elected as Vice President of the Drug Sector for the Chamber of Commerce of Lima for the 2026–2027 period, reflecting the company’s leadership in quality standards. Contact Information and Headquarters
For professional inquiries or pharmacovigilance reporting, the company can be reached at their central office in Lima:
Address: Av. Pablo Carriquiry 660, Piso 3, San Isidro, Lima, Peru. Phone: +51 1 2216662 or toll-free at 0800 74074. Email: farmacovigilancia@dympharmaperu.com. Av. Pablo Carriquiry 660, Piso 3, San Isidro, Lima, Peru D & M Pharma Peru S.A.C. Company Profile - EMIS
D & M Pharma Peru S.A.C. (Desarrollos y Marketing Farmacéutico) is a specialized pharmaceutical company headquartered in Lima, Peru. Established as an extension of a Chilean-founded group, it operates primarily as a wholesaler and marketer of specialized medications, with a strong focus on respiratory and dermatological therapies. 🏥 Company Overview Full Name: D & M Pharma Peru S.A.C. August 1, 2007 (Incorporated in Peru) Av. Pablo Carriquiry 660, Piso 3, San Isidro, Lima, Peru Key Partners: Strategic alliance with Laboratorio Cassará (Argentina), which joined the parent group in 2005. Workforce: Approximately 32 employees (as of 2024). Therapeutic Focus & Products
The company operates through five key divisions, often leveraging the established R&D and product lines of Laboratorio Cassará and other international partners. D&M Pharma Primary Therapeutic Areas Notable Products Respiratory & Dermatology Aerotrop (respiratory), Atopix (skin) Fouchard / Feelderm Advanced Dermatology Anagen (hair loss), Clidan (acne) Specialized Dermatology Targeted skin and hair care Ophthalmology Specialized eye drops and treatments Probiotics & GI Health Biocass (intestinal flora regulation) ⚖️ Regulatory & Market Standing Registration: All products must obtain a Sanitary Registration from
(Dirección General de Medicamentos, Insumos y Drogas), which falls under the Peruvian Ministry of Health.
Officially categorized under "Miscellaneous Nondurable Goods Merchant Wholesalers". Regional Presence:
While headquartered in Lima for local operations, it is part of a broader network that includes branches in Chile and Ecuador. Leadership: To survive, D & M Pharma must offer
Key figures include Dr. Mery Luz Peña García, who serves as Technical Director and was recently appointed as Vice President of the Medicines Sector at the Lima Chamber of Commerce (2026–2027). 📈 Strategic Direction
The company is currently in a growth phase, expanding its "Cassará" division to increase its reach to medical professionals. Their current strategy emphasizes: D&M Pharma Innovation:
Introducing new brands in the probiotic and dermatological spaces. Pharma-Vigilance:
Maintaining dedicated channels for reporting side effects to ensure patient safety. Local Commitment:
Reaffirming its role in the Peruvian healthcare system through leadership in trade groups like COMSALUD. dympharmaperu.com competitive analysis
comparing them to other Peruvian labs like Roxfarma or Medifarma. A deeper look into their regulatory compliance history with DIGEMID. A detailed product list breakdown for one of their specific divisions (e.g., Dermatology). D & M Pharma Peru S.A.C. Company Profile - EMIS
Any legitimate business in Peru must possess a RUC (Registro Único de Contribuyentes) — the tax identification number. D & M Pharma Peru SAC is expected to be registered under the Superintendencia Nacional de Aduanas y de Administración Tributaria (SUNAT) . Compliance with SUNAT is mandatory for invoicing, importing active pharmaceutical ingredients (APIs), and exporting finished goods.
The pharmaceutical market in Peru presents unique challenges, ranging from complex logistics to diverse demographic needs. D&M Pharma Peru S.A.C. differentiates itself through a strategic commercialization model. Rather than a "one-size-fits-all" approach, the company leverages deep market intelligence to position products effectively.
Their services typically include: